Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.962 EUR | -0.91% |
|
-0.41% | -25.11% |
Jun. 17 | Sanofi: positive phase 1/2 data in leukemia | CF |
Jun. 17 | Innate: positive phase 1/2 data in leukemia | CF |
Sales 2024 * | 50.51M 54.28M | Sales 2025 * | 70.33M 75.58M | Capitalization | 159M 171M |
---|---|---|---|---|---|
Net income 2024 * | -23M -24.72M | Net income 2025 * | -25M -26.87M | EV / Sales 2024 * | 1.1 x |
Net cash position 2024 * | 103M 111M | Net cash position 2025 * | 161M 173M | EV / Sales 2025 * | -0.03 x |
P/E ratio 2024 * |
-4.27
x | P/E ratio 2025 * |
3.27
x | Employees | 179 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 75.04% |
Latest transcript on Innate Pharma
1 day | -0.91% | ||
1 week | -0.41% | ||
Current month | +4.70% | ||
1 month | -22.45% | ||
3 months | -12.02% | ||
6 months | -25.68% | ||
Current year | -25.11% |
![Extreme 1.862](/images/extremecours_fleche.png)
![Extreme 1.862](/images/extremecours_fleche.png)
![Extreme 1.862](/images/extremecours_fleche.png)
![Extreme 1.862](/images/extremecours_fleche.png)
![Extreme 1.862](/images/extremecours_fleche.png)
![Extreme 1.862](/images/extremecours_fleche.png)
![Extreme 1.862](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Eric Vivier
FOU | Founder | 60 | 99-09-22 |
Chief Executive Officer | 62 | 99-09-22 | |
Frederic Lombard
DFI | Director of Finance/CFO | 49 | 21-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 62 | 99-09-22 | |
Gilles Brisson
BRD | Director/Board Member | 72 | 07-06-25 |
Olivier Martinez
BRD | Director/Board Member | 54 | 10-05-24 |
Date | Price | Change | Volume |
---|---|---|---|
24-07-02 | 1.962 | -0.91% | 28,751 |
24-07-01 | 1.98 | +5.66% | 86,640 |
24-06-28 | 1.874 | -5.92% | 126,910 |
24-06-27 | 1.992 | +1.12% | 54,357 |
24-06-26 | 1.97 | 0.00% | 45,710 |
Real-time Euronext Paris, July 02, 2024 at 11:35 am EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.11% | 172M | |
+17.72% | 44.44B | |
-10.33% | 37.99B | |
+37.55% | 37.75B | |
+29.36% | 30.78B | |
-8.44% | 27.38B | |
+12.45% | 26.17B | |
+44.19% | 14.15B | |
+31.93% | 12.59B | |
-7.67% | 11.28B |
- Stock Market
- Equities
- IPH Stock